The largest database of trusted experimental protocols

Recombinant rat igf 1

Manufactured by R&D Systems
Sourced in United States

Recombinant rat IGF-1 is a protein produced in a laboratory using recombinant DNA technology. It is the rat version of the Insulin-like Growth Factor 1 (IGF-1) protein, which is involved in cell growth and development processes.

Automatically generated - may contain errors

4 protocols using recombinant rat igf 1

1

Evaluating IGF-1 and DHT Effects on Dunning G Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dunning G cells (5000 cells/well) were seeded in 100 µl phenol-free RPMI (Gibco) supplemented with 2.5% charcoal stripped FBS (Gibco), in 96-well plates, and allowed to settle overnight. Culture medium was carefully removed and replaced with 100 µl phenol-free RPMI supplemented with 2.5% charcoal stripped FBS and various concentrations of recombinant rat IGF-1 (R&D Systems, Minneapolis, MN, US), dihydrotestosterone (DHT, Sigma-Aldrich, St Louis, MO, US) and NVP-AEW541, at doses previously described [13 (link)]. The relative amount of viable tumor cells was measured at baseline, and day 2, 4 and 7 using the Cell Proliferation Kit I (Roche Diagnostics, Bromma, Sweden) according to the manufacturer’s instructions. Cells that were cultured for 7 days received fresh media with supplements at day 4 of the experiment.
+ Open protocol
+ Expand
2

IGF-1 Effects on ICH-Induced Acute Brain Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant rat IGF-1 (R&D system, Minneapolis, MN, U.S.A.; 10 μg/ml) and a vehicle (PBS) were administered via intraperitoneal injection 30 min after the ICH surgery to assess the effects of IGF-1 on the regulation of ICH-induced acute brain injury.
+ Open protocol
+ Expand
3

Glucose Uptake in Neuronal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neurons were plated on glass bottom culture dishes and were used at 6–8 DIV. For the experiments, cultures were rinsed with glucose-free HCSS (120 mmol/l NaCl, 5.4 mmol/l KCl, 1.8 mmol/l CaCl2, 20 mmol/l HEPES pH 7.4) and kept for 45 min under glucose deprivation followed by exposure for 30 min to either mAß1−42 (100 nM), or recombinant rat IGF-1 (5 ng/ml, R&D Systems). The non-hydrolyzable glucose analog 6-NBDG was allowed to be internalized into neuronal cells at 37°C and 5% CO2 for 10 min. 6-NBDG+ neurons were imaged by using an Olympus FV1000 LSM. Images were captured at 488 excitation/505-550 emission.
+ Open protocol
+ Expand
4

IGF-1 Infusion and BrdU Labeling in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant rat IGF-1 was obtained from R&D Systems (Minneapolis, MN) diluted in saline and given at 4 μg/Kg/day as a continuous subcutaneous infusion using the Alzet osmotic mini-pumps (Model 2006, flow rate 1 μl/hr; Durect Co, Cupertino, CA). For the control group, equal volume of saline was loaded into osmotic pumps. Amount of IGF-1 was based on our pilot study and previous report [28 (link)]. Isofluorane was used for anesthetic induction and maintenance during surgical implantation of the pump subcutaneously (above the scapula) for each animal. Topical lidocaine was applied at the incision site after isofluorane induction for pain management. In addition, post-operative acetaminophen (200 mg/kg) was delivered in the drinking water 24 hours after pump implantation.
The thymidine analog Bromodeoxyuridine (Chemicon, Temecula, CA) was also given to label proliferating neural progenitor cells. Bromodeoxyuridine (BrdU) was dissolved in 0.9% sterile NaCl and filtered at 22 μm. The resulting solution was injected at 75 mg/kg intraperitoneally. BrdU injections were given for 3 consecutive days starting at two weeks after completion of the chemotherapeutic regimen.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!